Request an accessible format.
This factsheet outlines the domestic control measures that apply to cannabis, cannabidiol (CBD) and controlled cannabinoids.
This file may not be suitable for users of assistive technology.
Drug licensing factsheet: cannabis, CBD and other cannabinoids
This factsheet is intended to be used by existing licensees and prospective licensees who may need to apply for a licence. They should have fully assessed any proposals they may wish to make in the context of this guidance and that provided by other regulators.
This is intended as general guidance only; it is not legal advice. Anyone in doubt should seek their own independent legal advice to ensure they are compliant with any relevant legislation.
““cannabis-based product for medicinal use in humans” means a preparation or other product, other than one to which paragraph 5 of part 1 of Schedule 4 applies, which —
(b) is produced for medicinal use in humans; and—
In addition to any issues associated with controlled substance content, cannabis/ cannabis extract products may also need to satisfy other regulatory requirements if clinical/medicinal benefits are claimed. In this respect, companies may wish to contact the MHRA for their view on whether the cannabis/ cannabis extract products are additionally subject to their licensing regime and control.
THC-A and its control status
The regulation sets out:
This publication is available at https://www.gov.uk/government/publications/cannabis-cbd-and-other-cannabinoids-drug-licensing-factsheet/drug-licensing-factsheet-cannabis-cbd-and-other-cannabinoids
b) the controlled drug in any component part is packaged in such a form, or in combination with other active or inert substances in such a manner, that it cannot be recovered by readily applicable means or in a yield which constitutes a risk to health; and
We also take into account the applicant’s ability to satisfy the requirements of other relevant regulatory bodies (such as the Medicines and Healthcare Products Regulatory Agency (MHRA), Food Standards Agency (FSA) and Trading Standards) when deciding whether it would be appropriate to grant a licence, where they are relevant to the risk-based licensing assessment process we operate.
There is a common misconception within the CBD industry that a product is legal to sell if it contains no more than 0.2% THC.
This article summarises the laws affecting those supplying the CBD industry and those manufacturing or selling CBD products.
CBD UK Law for CBD Products
The same applies to other controlled cannabinoids.
So, the only way to know the true CBD or controlled cannabinoid content of a CBD concentrate is to have a sample tested in a reputable CBD testing lab.
You can import CBD into the UK without a license. However, the CBD needs to come from an EU-approved industrial hemp strain.